All In Biotech

Free tool

FAERS Monitor: Lo Loestrin Fe

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022501 or its brand name (Lo Loestrin Fe, Ethinyl Estradiol, Norethindrone Acetate). Reports on generic versions are filed under their own applications.

Reports

3,223

Serious

812

25% of reports

Hospitalization

254

Death reported

11

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use373
  • amenorrhoea220
  • nausea200
  • headache163
  • drug ineffective158
  • metrorrhagia156
  • anxiety147
  • fatigue139
  • depression121
  • menstruation irregular108
  • product dose omission issue107
  • dizziness104
  • inappropriate schedule of product administration104
  • pain96
  • menorrhagia80

Reports by year received

View as table
YearReports
20104
201112
201245
201328
201450
2015246
2016437
2017254
2018367
2019366
2020327
2021218
2022212
2023224
2024157
2025167
2026109

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,936 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
amenorrhoeaSignal22082.972.917,510
metrorrhagiaSignal15660.251.78,954
menorrhagiaSignal8026.721.51,946
menstruation irregularSignal10826.421.92,608
inappropriate schedule of product administrationSignal1043.83.1210
depressionSignal1213.52.9213
anxietySignal1473.42.9246
off label useSignal3732.82.5442
product dose omission issueSignal1072.42.085
headache1631.71.547
nausea2001.61.452
dizziness1041.41.110
fatigue1391.21.03
pain961.00.80
drug ineffective1580.80.710

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.